A yet unreported der(11)t(6;11)(p21;q21) included in a complex karyotype of a refractory anemia with ring sideroblasts and poor prognosis

Blood Cells, Molecules, and Diseases

Volumn 53, Issue 1-2, 2014, Pages 91-93

  De Souza, Daiane Correa ^a   De Figueiredo, Amanda Faria ^a   Mkrtchyan, Hasmik ^b   Othman, Moneeb A K ^b   Liehr, Thomas ^b   Dobbin, Jane ^a   Macedo Silva, Maria Luiza ^a   Abdelhay, Eliana ^a   De Souza Fernandez, Teresa ^a  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATR PROTEIN; HEMOGLOBIN; MIXED LINEAGE LEUKEMIA PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ATM GENE; BLAST CELL; CASE REPORT; CHROMOSOME 11; CHROMOSOME 21P; CHROMOSOME 21Q; CHROMOSOME 6; CHROMOSOME ANALYSIS; CHROMOSOME REARRANGEMENT; DISEASE ASSOCIATION; DYSERYTHROPOIESIS; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HYPERPLASIA; KARYOTYPE; LETTER; LEUKOCYTE; MALE; MIDDLE AGED; MLL GENE; MYELOGRAPHY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; REFRACTORY ANEMIA WITH RINGED SIDEROBLASTS; THROMBOCYTOPENIA; ANEMIA, REFRACTORY; CHROMOSOME DELETION; GENE TRANSLOCATION; GENETICS; PATHOLOGY;

ANEMIA, REFRACTORY; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 6; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPE; MALE; MIDDLE AGED; PROGNOSIS; TRANSLOCATION, GENETIC;

EID: 84900006741     PISSN: 10799796     EISSN: 10960961     Source Type: Journal    
DOI: 10.1016/j.bcmd.2013.12.006     Document Type: Letter

References (8)

1. Ohba R., Furuyama K., Yoshida K., et al. Clinical and genetic characteristics of congenital sideroblastic anemia: comparison with myelodysplastic syndrome with ring sideroblast (MDS-RS). Ann. Hematol. 2013, 92:1-9.
2. el-Rifai W., Pettersson T., Larramendy M.L., et al. Lineage involvement and karyotype in a patient with myelodysplasia and blood basophilia. Eur. J. Haematol. 1994, 53:288-292.
3. Liehr T., Heller A., Starke H., et al. Microdissection based high resolution multicolor banding for all 24 human chromosomes. Int. J. Mol. Med. 2002, 9:335-339.
4. Khodadoust M.S., Verhaegen M., Kappes F., et al. Melanoma proliferation and chemoresistance controlled by the DEK oncogene. Cancer Res. 2009, 69:6405-6413.
5. von Lindern M., van Baal S., Wiegant J., et al. Can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3' half to different genes: characterization of the set gene. Mol. Cell. Biol. 1992, 12:3346-3355.
6. Cerveira N., Bizarro S., Teixeira M.R. MLL-SEPTIN gene fusions in hematological malignancies. Biol. Chem. 2011, 392:713-724.
7. Stern N., Hochman A., Zemach N., et al. Accumulation of DNA damage and reduced levels of nicotine adenine dinucleotide in the brains of Atm-deficient mice. J. Biol. Chem. 2002, 277:602-608.
8. Stam R.W., den Boer M.L., Passier M.M.C.J., et al. Silencing of the tumor suppressor gene FHIT is highly characteristic for MLL gene rearranged infant acute lymphoblastic leukemia. Leukemia 2006, 20:264-271.